PI
IART icon

PineBridge Investments’s Integra LifeSciences IART Stock Holding History

PineBridge Investments’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,072
Closed -$167K – 835
2023
Q2 		$167K Buy
4,072
+2,620
+180% +$126K ﹤0.01% 546
2023
Q1 		$83.4K Buy
+1,452
New +$81.8K ﹤0.01% 553
2022
Q2 		– Sell
-45,504
Closed -$2.92M – 759
2022
Q1 		$2.92M Sell
45,504
-956
-2% -$62.9K 0.03% 356
2021
Q4 		$3.11M Buy
46,460
+13,033
+39% +$882K 0.03% 359
2021
Q3 		$2.29M Buy
+33,427
New +$2.36M 0.03% 375
2018
Q2 		– Sell
-43,813
Closed -$2.42M – 1108
2018
Q1 		$2.42M Sell
43,813
-6,183
-12% -$324K 0.06% 300
2017
Q4 		$2.39M Buy
49,996
+25,042
+100% +$1.23M 0.06% 297
2017
Q3 		$1.26M Buy
24,954
+16,983
+213% +$872K 0.03% 471
2017
Q2 		$435K Buy
7,971
+174
+2% +$8.31K 0.01% 670
2017
Q1 		$329K Buy
7,797
+67
+0.9% +$2.86K 0.01% 710
2016
Q4 		$332K Buy
7,730
+130
+2% +$5.28K 0.01% 739
2016
Q3 		$313K Buy
7,600
+238
+3% +$9.97K 0.01% 372
2016
Q2 		$293K Buy
7,362
+308
+4% +$11.1K 0.02% 375
2016
Q1 		$238K Sell
7,054
-690
-9% -$21.5K 0.01% 424
2015
Q4 		$262K Buy
7,744
+668
+9% +$20.9K 0.01% 429
2015
Q3 		$210K Sell
7,076
-53
-0.7% -$1.66K 0.01% 501
2015
Q2 		$197K Sell
7,129
-8,783
-55% -$234K 0.01% 501
2015
Q1 		$401K Buy
15,912
+1,744
+12% +$41.2K 0.01% 501
2014
Q4 		$314K Buy
14,168
+918
+7% +$18.6K 0.01% 554
2014
Q3 		$269K Buy
13,250
+4,362
+49% +$86.8K 0.01% 542
2014
Q2 		$171K Sell
8,888
-5,480
-38% -$102K 0.01% 608
2014
Q1 		$270K Sell
14,368
-1,377
-9% -$26.6K 0.01% 649
2013
Q4 		$307K Buy
15,745
+10,189
+183% +$187K 0.01% 630
2013
Q3 		$91K Hold
5,556
– – ﹤0.01% 752
2013
Q2 		$83K Buy
+5,556
New +$81.4K ﹤0.01% 768

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PineBridge Investments's IART Position: Q3 2023 in Review

PineBridge Investments sold out of Integra LifeSciences (IART) in Q3 2023, closing a stake of 4,072 shares — an estimated $167K sold.

PineBridge Investments first reported a position in IART in Q2 2013 and held it in 25 quarters. The position peaked at $3.11M in Q4 2021. 262 funds tracked by Wall St. Rank hold IART as of Q3 2023.

  • PineBridge Investments reported no remaining Integra LifeSciences position as of Q3 2023 after selling out during the quarter.
  • PineBridge Investments sold 4,072 Integra LifeSciences shares in Q3 2023, an estimated $167K.
  • PineBridge Investments first reported a position in Integra LifeSciences in Q2 2013 and held it in 25 quarters.
  • PineBridge Investments's Integra LifeSciences position peaked at $3.11M in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2023.

Based on PineBridge Investments's 13F filing for Q3 2023, filed 14 Nov 2023.